支气管扩张合并肺诺卡菌病1例
A Case of Bronchiectasis Complicated with Pulmonary Nocardiosis
DOI: 10.12677/acm.2025.1561917, PDF,   
作者: 许伟霞:暨南大学附属第一医院呼吸与危重症医学科,广东 广州;谢衬梨*:东莞市滨海湾中心医院呼吸与危重症医学科,广东 东莞
关键词: 支气管扩张症肺诺卡菌病感染Bronchiectasis Pulmonary Nocardiosis Infection
摘要: 诺卡菌感染相对罕见,通常发生在免疫缺陷患者中。在这里,我们介绍了一例免疫功能低下的青年患者因皮疽诺卡菌引起的肺部感染。本例中,一名26岁的男性因咳嗽和咳痰超过10年,加重伴发热2天入院,既往被诊断患有支气管扩张症。入院后常规治疗效果不佳,病情反复,完善痰培养和纤维支气管镜取肺泡灌洗液通过多重靶向扩增–高通量测序法技术鉴定为皮疽诺卡菌感染。调整治疗方案为口服复方磺胺甲噁唑片来控制感染,规范治疗1个月后肺部炎症逐渐消退。
Abstract: Nocardia infection is relatively rare and usually occurs in immunocompromised patients. Here, we present a case of a young immunocompromised patient with a lung infection caused by Nocardia serrata. In this case, a 26-year-old male was admitted to the hospital with cough and sputum for more than 10 years, which worsened with fever for 2 days. He was previously diagnosed with bronchiectasis. After admission, conventional treatment was ineffective and the condition recurred. Sputum culture and bronchoalveolar lavage fluid obtained by fiberoptic bronchoscopy were identified as Nocardia serrata infection by multiple targeted amplification-high-throughput sequencing technology. The treatment plan was adjusted to oral trimethoprim-sulfamethoxazole tablets to control the infection. After 1 month of standardized treatment, the lung inflammation gradually subsided.
文章引用:许伟霞, 谢衬梨. 支气管扩张合并肺诺卡菌病1例[J]. 临床医学进展, 2025, 15(6): 1803-1807. https://doi.org/10.12677/acm.2025.1561917

参考文献

[1] Chen, C., Huang, Y., Yuan, J., Li, H., Han, X., Martinez-Garcia, M.A., et al. (2020) The Roles of Bacteria and Viruses in Bronchiectasis Exacerbation: A Prospective Study. Archivos de Bronconeumología (English Edition), 56, 621-629. [Google Scholar] [CrossRef] [PubMed]
[2] González-Jiménez, P., Méndez, R. and Latorre, A. (2022) Pulmonary Nocardiosis. A Case Report. Revista Española de Quimioterapia, 35, 114-116. [Google Scholar] [CrossRef] [PubMed]
[3] Conville, P.S., Brown-Elliott, B.A., Smith, T. and Zelazny, A.M. (2018) The Complexities of Nocardia Taxonomy and Identification. Journal of Clinical Microbiology, 56, e01419-17. [Google Scholar] [CrossRef] [PubMed]
[4] Abdelmegid, O., Thakur, S. and Cheung, A.Y. (2023) Nocardia Arthritidis Scleritis: A Case Report. American Journal of Ophthalmology Case Reports, 29, Article 101794. [Google Scholar] [CrossRef] [PubMed]
[5] Saubolle, M.A. and Sussland, D. (2003) Nocardiosis. Journal of Clinical Microbiology, 41, 4497-4501. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, C., Sun, Q., Yan, J., Liao, X., Long, S., Zheng, M., et al. (2023) The Species Distribution and Antimicrobial Resistance Profiles of Nocardia Species in China: A Systematic Review and Meta-Analysis. PLOS Neglected Tropical Diseases, 17, e0011432. [Google Scholar] [CrossRef] [PubMed]
[7] Beaman, B.L., Burnside, J., Edwards, B. and Causey, W. (1976) Nocardial Infections in the United States, 1972-1974. Journal of Infectious Diseases, 134, 286-289. [Google Scholar] [CrossRef] [PubMed]
[8] Fatahi-Bafghi, M. (2018) Nocardiosis from 1888 to 2017. Microbial Pathogenesis, 114, 369-384. [Google Scholar] [CrossRef] [PubMed]
[9] Deem, R.L., Doughty, F.A. and Beaman, B.L. (1983) Immunologically Specific Direct T Lymphocyte-Mediated Killing of Nocardia Asteroides. The Journal of Immunology, 130, 2401-2406. [Google Scholar] [CrossRef
[10] Brown-Elliott, B.A., Brown, J.M., Conville, P.S. and Wallace, R.J. (2006) Clinical and Laboratory Features of Thenocardiaspp. Based on Current Molecular Taxonomy. Clinical Microbiology Reviews, 19, 259-282. [Google Scholar] [CrossRef] [PubMed]
[11] Han, Y., Cheng, M., Li, Z., Chen, H., Xia, S., Zhao, Y., et al. (2024) Clinical Characteristics and Drug Resistance of Nocardia in Henan, China, 2017-2023. Annals of Clinical Microbiology and Antimicrobials, 23, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[12] Huang, L., Sun, L. and Yan, Y. (2019) Characteristics of Nocardiosis Patients with Different Immune Status from a Chinese Tertiary General Hospital during 8-Year Period. Medicine, 98, e17913. [Google Scholar] [CrossRef] [PubMed]
[13] Alavi Darazam, I., Shamaei, M., Mobarhan, M., Ghasemi, S., Tabarsi, P., Motavasseli, M., et al. (2013) Nocardiosis: Risk Factors, Clinical Characteristics and Outcome. Iranian Red Crescent Medical Journal, 15, 436-439. [Google Scholar] [CrossRef] [PubMed]
[14] Gonzalez, L.M., Venkatesan, R., Amador, P., Sanivarapu, R.R. and Rangaswamy, B. (2024) TB or Not TB: Lung Nocardiosis, a Tuberculosis Mimicker. Cureus, 16, e55412. [Google Scholar] [CrossRef] [PubMed]
[15] Kanne, J.P., Yandow, D.R., Mohammed, T.H. and Meyer, C.A. (2011) CT Findings of Pulmonary Nocardiosis. American Journal of Roentgenology, 197, W266-W272. [Google Scholar] [CrossRef] [PubMed]
[16] Liu, C., Yang, J., Huang, H., Zhan, S. and Xia, X. (2022) Case Report: Nocardia Gipuzkoensis Infection in an Immunocompetent Patient Diagnosed by Metagenomic Next-Generation Sequencing and Whole Genome Sequencing. Frontiers in Immunology, 13, Article 1053914. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, H., Zhu, Y., Cui, Q., Wu, W., Li, G., Chen, D., et al. (2022) Epidemiology and Antimicrobial Resistance Profiles of the nocardia Species in China, 2009 to 2021. Microbiology Spectrum, 10, e0156021. [Google Scholar] [CrossRef] [PubMed]
[18] Moylett, E.H., Pacheco, S.E., Brown-Elliott, B.A., Perry, T.R., Buescher, E.S., Birmingham, M.C., et al. (2003) Clinical Experience with Linezolid for the Treatment of Nocardia Infection. Clinical Infectious Diseases, 36, 313-318. [Google Scholar] [CrossRef] [PubMed]
[19] Vera-Cabrera, L., Gómez-Flores, A., Escalante-Fuentes, W.G. and Welsh, O. (2001) In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against nocardia Brasiliensis. Antimicrobial Agents and Chemotherapy, 45, 3629-3630. [Google Scholar] [CrossRef] [PubMed]
[20] Shen, T., Wu, L., Geng, L., Wei, Z. and Zheng, S. (2011) Successful Treatment of Pulmonary Nocardia Farcinica Infection with Linezolid: Case Report and Literature Review. The Brazilian Journal of Infectious Diseases, 15, 486-489. [Google Scholar] [CrossRef] [PubMed]